• to lessen the chance of major cardiovascular (heart and blood vessel) complications in Older people with variety two diabetes and cardiovascular diseaseIn Oct 2024, Novo Nordisk revealed a analyze on scientific journal Mother nature a few novel glucose-delicate insulin NNC2215 that may lessen the risk of hypoglycemia in animal models.[67]By 202